8.6. eau-esmo consensus statements management advanced- variant bladder cancer *. consensus statementafter radical cystectomy curative intent, regular follow-up needed.after radical cystectomy curative intent, follow-up detection second cancers urothelium recommended.after radical cystectomy curative intent, follow-up urethra cytology and/or cystoscopy recommended selected patients (e.g., multifocality, carcinoma situ tumour prostatic urethra).after trimodality treatment curative intent, follow-up detection relapse recommended every 3–4 months initially; 3 years, every 6 months majority patients.after trimodality treatment curative intent, regular cystoscopic evaluation bladder wall needed.after trimodality treatment curative intent, follow-up imaging ct thorax abdomen assess distant recurrence recurrence outside bladder needed.in patients partial complete response chemotherapy metastatic urothelial cancer, regular follow-up needed. imaging studies may done according signs/symptoms.in patients treated radical cystectomy curative intent neobladder, management acid bases household includes regular measurements ph sodium bicarbonate substitution according measured value.to detect relapse radical cystectomy curative intent, ct thorax abdomen recommended five years post-operatively.vitamin b12 levels measured annually follow-up patients treated radical cystectomy bowel diversion curative intent. *only statements met priori consensus threshold across three stakeholder groups listed (defined ≥ 70% agreement ≤ 15% disagreement, vice versa).ct = computed tomography.